[ASAP] Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization 🔗 Access full article via ACS Molecular Pharmaceutics Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00860 Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
